http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1646874-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19728d927b5a38e194fcc2f3e79e0b00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2004-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2010-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f82bf0cc47b27c649a31d039e4d3e74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aab66e6143741486d8f4b977a647c08e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cada05daf867120f097c46d5bbcd5ede |
publicationDate | 2010-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1646874-B1 |
titleOfInvention | A method for predicting the metastatic potential of breast cancer |
abstract | A process for determining whether a tumor sample has potential for tumor progression is provided whereby the overexpression of four genes, transmembrane receptor tyrosine kinase DDR2, transmembrane receptors PMP22 and EMP3 and cell adhesion molecule N-cadherin in a sample is analyzed. Kits suitable for performing the invention are also provided. Methods for deriving a candidate agent are also disclosed. |
priorityDate | 2003-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1433.